Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. (TNGX) is a healthcare company (biotechnology) based in the United States. The share price is $22.30, down 7.74% on the day, which values the company at $3.78B. Price as of 17 Nov 2026, 19:11 UTC, from Yahoo Finance.

Key facts

Share price
$22.30−7.74% today
Market value
$3.78B
Funk Score
44/100
Against its own history
Well above its usual priceusual price $8.73
200-week average
$9.97124% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Tango Therapeutics, Inc. in more detail

TNGX trades at -12.4× next year's expected earnings. Measured against its own history, the price is 155% above what its usual multiples would imply ($8.73) — well above its usual price. It sits 124% above its 200-week average of $9.97.

Over the last five fiscal years Tango Therapeutics, Inc. has compounded revenue 52.1% a year. Its Funk Score is 44 out of 100 (financial strength 8.3, profitability 0.0, growth 9.3, value 0.0, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Share count keeps rising; Heavy stock-based pay.

2 of the superinvestors tracked here hold TNGX, including Andrew Spokes (0.6% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding TNGX

2 of the investors tracked here report a position in their latest 13F filing.

Tango Therapeutics, Inc. (TNGX): questions and answers

What is Tango Therapeutics, Inc.'s market cap?

Tango Therapeutics, Inc. is valued at $3.78B at a share price of $22.30.

Is TNGX overvalued or undervalued?

Against its own history, TNGX is well above its usual price: the price is 155% above the $8.73 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is TNGX above its 200-week moving average?

Yes. TNGX is 123.6% above its 200-week average of $9.97. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Tango Therapeutics, Inc. growing?

Over the last five fiscal years Tango Therapeutics, Inc.'s revenue grew 52.1% a year.

Does TNGX pay a dividend?

Tango Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own TNGX?

In their latest quarterly filings, Andrew Spokes (0.6% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold TNGX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Tango Therapeutics, Inc. (TNGX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TNGX

Underlying data: Yahoo Finance; company filings with the SEC.